Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 8,265.0 | 6,515.0 | 7,862.0 | 6,723.0 | 554.0 | 5,968.0 | 6,140.0 | 5,737.0 |
| Revenue growth | 26.9% | -17.1% | 16.9% | 1113.5% | -90.7% | -2.8% | 7.0% | -12.5% |
| Cost of goods sold | 5,564.0 | 5,530.0 | 5,168.0 | 4,522.0 | 1,928.0 | 1,911.0 | 1,846.0 | 1,762.0 |
| Gross profit | 2,701.0 | 985.0 | 2,694.0 | 2,201.0 | -1,374.0 | 4,057.0 | 4,294.0 | 3,975.0 |
| Gross margin | 32.7% | 15.1% | 34.3% | 32.7% | -248.0% | 68.0% | 69.9% | 69.3% |
| Selling, general and administrative | | | | | 591.0 | 567.0 | 508.0 | 390.0 |
| Sales and marketing | 107.0 | 104.0 | 162.0 | 147.0 | | | | |
| Research and development | 388.0 | 362.0 | 422.0 | 285.0 | 245.0 | 234.0 | 224.0 | 212.0 |
| General and administrative | 125.0 | 115.0 | 152.0 | 122.0 | 474.0 | 110.0 | 61.0 | 15.0 |
| EBITA | 3,441.0 | 2,159.0 | 4,039.0 | 2,954.0 | 2,983.0 | 2,788.0 | 2,842.0 | 2,127.0 |
| EBITA margin | 41.6% | 33.1% | 51.4% | 43.9% | 538.4% | 46.7% | 46.3% | 37.1% |
| Amortization of intangibles | 47.0 | 55.0 | 54.0 | 5.0 | 2.0 | 2.0 | 2.0 | 4.0 |
| EBIT | 3,394.0 | 2,104.0 | 3,985.0 | 2,949.0 | 2,981.0 | 2,786.0 | 2,840.0 | 2,123.0 |
| EBIT margin | 41.1% | 32.3% | 50.7% | 43.9% | 538.1% | 46.7% | 46.3% | 37.0% |
| Pre-tax income | 3,517.0 | 1,797.0 | 3,202.0 | 2,765.0 | 2,979.0 | 2,208.0 | 2,365.0 | 2,028.0 |
| Income taxes | 747.0 | 370.0 | 690.0 | 572.0 | 799.0 | 665.0 | 659.0 | 545.0 |
| Tax rate | 21.2% | 20.6% | 21.5% | 20.7% | 26.8% | 30.1% | 27.9% | 26.9% |
| Net income | 2,659.0 | 1,323.0 | 2,419.0 | 2,118.0 | 2,105.0 | 1,472.0 | 1,637.0 | 1,414.0 |
| Net margin | 32.2% | 20.3% | 30.8% | 31.5% | 380.0% | 24.7% | 26.7% | 24.6% |
| |
| Diluted EPS | $3.74 | $1.84 | $3.36 | $3.09 | $2.84 | $1.93 | $2.03 | $1.68 |
| Shares outstanding (diluted) | 711.2 | 719.7 | 720.1 | 685.5 | 740.7 | 764.5 | 807.7 | 843.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|